Chad Beyer Email & Phone

Chief Executive Officer @ Kures

Senior Vice President Research and Development @ Promentis Pharmaceuticals

Entrepreneur in Residence @ Lafayette College

President and Chief Executive Officer @ Promentis Pharmaceuticals

Vice President, Research and Development @ Ariel Pharmaceuticals

Drug Development Consultant @ Solomon Therapeutics

Head of Neurochemistry @ Pfizer

Principal Research Scientist @ Pfizer

- 2009 Master of Business Administration @

2005 - 2009 Master of Business Administration @ Rutgers Business School

- 2000 @ Louisiana State University Medical Center

1996 - 2000 Doctor of Philosophy @ Louisiana State University Health Sciences Center

1992 - 1996 Bachelor of Science @ Allegheny College

Chromatography, Interplay, Clinical Trials, Medical Writing, Psychiatry, Cell Biology, In Vivo, Neuroscience, Infectious Diseases, Cost, Clinical Research, Biotechnology, Alzheimer's disease, Regulatory Affairs, Immunology, Louisiana, Strategy Alignment, NMR, Symposium, Families, Sbir, Stress, Clinical Development, Capital Equipment, Disease, Book Chapters, Cancer, Microbiology, Pain Management, Management, Design, GLP, Resume, Toxicology, Journals, Patents, Therapeutic Areas, Schizophrenia, Protein Chemistry, Key Opinion Leaders, Interpreting Data, Initiation, Dealing, Publications, Public Speaking, Scientific Background, Parkinson's, Collaborative, HPLC, Golf, Consumer, Cell, Healthcare, Project Leadership, Baltimore, Reports, Branding, Lifesciences, Drug Delivery, Medicine, Medical Liaison, Oncology, Drug Development, Bioethics, Regulatory Submissions, Institutes, Medicinal Chemistry, Image, Conferences, Operational Excellence, Project Management, Informatics, Research, Task Force, Commercial Real Estate, Investigation, R&d, Analysis, Campaigns, Partnerships, Abstracts, Biopharmaceuticals, Cut, Jersey, Applications, Assay Development, Debate, Business Development, Communication, Greenwood Village, Brain, Cell Culture, Efficacy, Vast, Active, Scientific, Safety, Editorial, Regulatory Requirements, Suite, Author, Drug Discovery, Molecular Biology, Analytical Chemistry, Commercial Products, Visibility, Marketing, Colorado, Depression, Molecular Genetics, Neurobiology, Neuropharmacology, Lives, Pipelines, Pharmacology, Drug Safety, Genetics, Biochemistry, Technology Transfer, Presentations, Multi Disciplinary, Responsibility, Council, Therapists, Roadmap, International, Translational Medicine, Art, CRO, Small Molecules, ELISA, High Quality, Clinical Pharmacology, New York, Grants, Investments, Guidelines, Discovering, On Line, Throughput, Psychology, Profiles, Organic Chemistry, Cell Based, Neurochemistry, Pharmaceutics, Addictions, In Vitro, Mood Disorders, Lc Ms, Therapeutic Area, Vaccines, Competitive Landscape, Budgets, Business Strategy, Scientists, Pharmaceutical Industry, Meetings, Directing, Biomarkers, Women's Health, FDA, Convenience, Bioscience, Commercialization, Pharmacokinetics, Quality Results

Chad Beyer, based in Princeton, NJ, US, is currently a Chief Executive Officer at Kures. Chad Beyer brings experience from previous roles at Promentis Pharmaceuticals, Lafayette College, Promentis Pharmaceuticals, Ariel Pharmaceuticals, Solomon Therapeutics, Pfizer, Pfizer. Chad Beyer holds various educational qualifications including Master of Business Administration . With a robust skill set that includes Chromatography, Interplay, Clinical Trials, Medical Writing, Psychiatry, Chad Beyer demonstrates proficiency in a wide range of areas.